Industry News

Industry News's picture
Keywords: 

Newport Beach, CA – January 9, 2018 –Ventris Medical, a Newport Beach-based healthcare company, today announced the company’s official launch. The company also is launching its full line of placental allograft products that will be used in surgical and non-surgical applications.

Blog Category: 
Industry News's picture
Keywords: 

Suwanee, GA – January 2, 2018 – SANUWAVE Health, Inc. (OTCQB: SNWV) has announced that the US Food and Drug Administration (FDA) has issued its decision on the de novo submission for the dermaPACE® System

Blog Category: 
Industry News's picture

Tempe, Arizona - December 5, 2017 Vomaris Innovations, Inc. announced today breakthrough results of the first controlled, preclinical in vivo evidence on the anti-biofilm impact of the Company’s bioelectric antimicrobial technology. The study found that the technology can prevent and disrupt biofilm infection and restore functional wound healing. The manuscript, “Electric Field Based Dressing Disrupts Mixed-Species Bacterial Biofilm Infection and Restores Functional Wound Healing,” was published online in the Annals of Surgery. The research was led by Chandan Sen, Ph.D., Professor of Surgery and Director of the Comprehensive Wound Center at The Ohio State University’s Wexner Medical Center.

Blog Category: 
Industry News's picture
Keywords: 

by The Wound Healing Foundation
This update from the Wound Healing Foundation (WHF) provides an overview of current and future educational, research and community-based initiatives in wound care. Recent WHF activities and opportunities include participation in international dialogue and meetings, as well as the ongoing efforts to advance and support scientific research in the field of wound management.

Blog Category: 
Industry News's picture

Springdale, OH – November 14, 2017 – The National Association of Directors of Nursing Administration (NADONA) recently announced a new public/private partnership with Ocean Spray Cranberries designed to target Antibiotic Resistance and improve Antibiotic Stewardship efforts in America's Long-Term Care and Post-Acute Care healthcare facilities. This partnership is focused on clinical education, research, and public policy and advocacy to improve Antibiotic Stewardship across the continuum of care.

Blog Category: 
Jeffrey M. Levine's picture

by Jeffrey Levine MD

Please join me Thursday, November 16 from 3:00-4:00pm EST for a free webinar presented by myself and Elizabeth A. Ayello, PhD, RN, ACNS-BC, CWOCN, ETN, MAPWCA, FAAN sponsored by the National Pressure Ulcer Advisory Panel (NPUAP), entitled, Unavoidable Pressure Injuries, Terminal Ulceration, and Skin Failure: Where Are We and Where Are We Going?

Industry News's picture

by The Alliance of Wound Care Stakeholders

In their quarterly Alliance Advocacy Update, the Alliance of Wound Care Stakeholders (Alliance) provides an update on their ongoing advocacy initiatives on behalf of their clinical association members to ensure access, coverage and payment to wound care procedures and technologies for patients and providers.

Blog Category: 
Industry News's picture

San Diego, CA – October 3, 2017 – CogenDx, the genetics brand of Millennium Health, LLC, announced the launch of its newest test offering, DxWound. The test uses DNA-based technology to provide accurate, sensitive detection of an array of microbes, including aerobic and anaerobic bacteria, fungi, plus antibiotic resistance genes. Results from the tests equip clinicians to rapidly and accurately identify potential pathogens causing infections and select antibiotics with greater likelihood for efficacy.

Blog Category: 
Industry News's picture

Chicago, IL – October 23, 2017 – Global medical technology company Hill-Rom (NYSE: HRC) today announced the launch of a new medical-surgical bed solution for hospitals that offers optimized patient safety, enhanced patient satisfaction and advanced caregiver-focused technology. The new Hill-Rom® Centrella™ Smart+ bed is available now in the U.S., and in Canada in November.

Blog Category: 
Industry News's picture

Marietta, GA – October 11, 2017 – MiMedx Group, Inc. (NASDAQ: MDXG), a leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare, announced today that the latest peer-reviewed clinical study of MiMedx dehydrated human amnion/chorion membrane ("dHACM") allografts has been published in the International Wound Journal.

Blog Category: